Summit Therapeutics Inc. · NASDAQ:SMMT

Duggan Robert W exercised options for 300,000 Summit Therapeutics Inc. shares (Form 4)

Traded Nov 20, 2026 · Filed Nov 20, 2026

On Nov 20, 2026, Duggan Robert W (Director, Co-Chief Executive Officer, 10% owner) exercised options for 300,000 Summit Therapeutics Inc. shares at US$1.06 for US$318K, leaving 831,000 shares. Filed Nov 20, 2026 (Form 4).

Options exercised
300,000 shares
Price
US$1.06
Value
US$318K
Holding after
831,000 shares (held indirectly)
Trading plan
No
Role
Director, Co-Chief Executive Officer, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 20, 2026Common StockOption exercise300,000US$1.06831,000Indirect

Source

Download original · View original at SEC

Related